XML 58 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Stock-Based Compensation  
Schedule of assumptions used in the fair value estimation of each option grant

December 31, 

    

2023

    

2022

    

2021

Expected life (years)

3.8 - 5.2

3.8 – 5.2

3.5 - 6.1

Risk-free interest rate

 

3.5% - 4.4%

2.1% - 3.7%

0.47% - 1.18%

Volatility

69.9% - 80.0%

67.5% – 78.6%

64.4% – 80.8%

Dividend yield

 

0%

0%

0%

Schedule of stock-based compensation expense related to all of our share-based payment awards

Total stock-based compensation expense related to our share-based payment awards is comprised of the following (in thousands):

Year Ended December 31, 

    

2023

    

2022

    

2021

Cost of revenues

$

2,216

$

1,459

$

1,620

Selling, general and administrative

 

18,805

 

16,808

 

12,425

Engineering and development

 

1,787

 

1,815

 

1,300

$

22,808

$

20,082

$

15,345

Schedule of stock option activity

Weighted-

Weighted-

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic

    

Shares

    

Price/Share

    

Term (Years)

    

Value (1)

Outstanding — December 31, 2020

 

7,554,305

$

10.29

 

 

  

Granted (weighted-average fair value of $32.79 per share)

 

541,353

56.61

 

 

  

Exercised

 

(1,037,910)

 

8.66

 

 

  

Forfeited

 

(29,807)

 

40.56

 

 

  

Outstanding — December 31, 2021

 

7,027,941

13.97

 

 

  

Granted (weighted-average fair value of $17.17 per share)

589,287

30.12

Exercised

 

(206,898)

 

9.90

 

 

Forfeited

 

(69,809)

 

43.42

 

 

Outstanding — December 31, 2022

7,340,521

15.10

Granted (weighted-average fair value of $11.86 per share)

432,990

20.63

Exercised

 

(407,814)

 

3.63

 

Forfeited

(140,877)

24.82

Outstanding — December 31, 2023

 

7,224,820

$

15.88

 

4.3

$

34,594

Vested (exercisable) — December 31, 2023

 

6,356,813

$

13.88

 

4.1

$

34,545

Expected to vest after December 31, 2023 (unexercisable)

 

868,007

$

30.55

 

5.7

$

49

(1)Aggregate intrinsic value represents the difference between the exercise price of the option and the closing market price of the Company’s common stock on December 29, 2023, (the last trading day of the year) which was $15.49 per share.
Summary of stock options outstanding and exercisable

The following table summarizes information with respect to stock options outstanding and exercisable at December 31, 2023:

Weighted-

Average

Weighted-

Weighted-

 

Remaining

 

Average

 

Average

 

Number

 

Contractual

 

Exercise

 

Number

Exercise

Exercise Price

    

Outstanding

    

Life -Years

    

Price

    

Exercisable

    

Price

$1.87 – 3.21

 

729,900

 

2.3

$

2.52

 

729,900

$

2.52

$3.38 – 4.92

 

859,202

 

2.1

$

4.35

 

859,202

$

4.35

$5.00 – 7.89

 

925,116

 

1.6

$

5.8

 

925,116

$

5.8

$8.17 – 11.88

 

721,994

 

4.4

$

9.13

 

721,994

$

9.13

$12.53 – 15.81

 

910,362

 

5.3

$

13.32

 

892,984

$

13.33

$16.59 – 16.95

 

1,162,867

 

6.2

$

16.92

 

1,049,018

$

16.93

$17.36 – 36.68

 

1,319,922

 

5.9

$

24.89

 

754,257

$

23.75

$41.14 – 72.07

 

595,457

 

4.9

$

54.70

 

424,342

$

54.49

 

7,224,820

 

6,356,813

Schedule of restricted stock unit activity

    

    

Weighted Average

Number of Restricted

Fair Value per

Stock Units

Share

Outstanding — December 31, 2021

373,849

$

55.53

Granted

526,821

30.26

Share issuance

(101,070)

55.43

Forfeited

(71,616)

44.4

Outstanding – December 31, 2022

 

727,984

$

38.32

Granted

 

667,319

 

19.80

Share issuance

 

(228,932)

 

37.63

Forfeited

 

(89,742)

 

29.34

Outstanding – December 31, 2023

 

1,076,629

$

27.73